Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC
Pfizer Inc. Chief Executive Officer Albert Bourla says President Donald Trump's nominee to lead the Centers for Disease Control and Prevention is a good choice. Bourla says Erica Schwartz is a "very credible scientist." Bourla also talks about earnings, their drug pipeline and doing business in China. He speaks to Bloomberg's David Westin.
More from Australia
Immuron hit with 44% first strike vote
Northern Star’s new CEO says performance has fallen short
ASX finds Austral breached rules on A$6.9m deals
Tasmea’s second FY27 guidance upgrade points to 80% earnings growth
MinRes scraps executive exit pay vote as investor support falls short
Woolworths unveils $10b sales growth plan to investors